1365-2125/asset/olbannerleft.gif?v=1&s=e86b92cac3efbbd2e255b9fa97ece9623eac0b54)
1365-2125/asset/olbannerright.gif?v=1&s=6a7c47d290382bf3bc40c62461bc36a371a081bf)
You have free access to this content
Two cheers or three for treatment guidelines? Nudging prescribers in right directions
Article first published online: 9 NOV 2011
DOI: 10.1111/j.1365-2125.2011.04122.x
© 2011 The Authors. British Journal of Clinical Pharmacology © 2011 The British Pharmacological Society
Additional Information
How to Cite
Loke, Y. K. and Ritter, J. M. (2011), Two cheers or three for treatment guidelines? Nudging prescribers in right directions. British Journal of Clinical Pharmacology, 72: 869–870. doi: 10.1111/j.1365-2125.2011.04122.x
Publication History
- Issue published online: 9 NOV 2011
- Article first published online: 9 NOV 2011
REFERENCES
- 1, , , . Regulation – the real threat to clinical research. BMJ 2008; 337: a1732.
- 2. When in doubt consider accrual into a randomized controlled clinical trial (RCT). Br J Clin Pharmacol 2008; 66: 169–72.
- 3. The checklist. The New Yorker, Dec 10th 2007.
- 4, , , , , , . The quality of health care delivered to adults in the United States. N Engl J Med 2003; 348: 2635–45.
- 5, , , , . Breaking the rules: understanding non-compliance with policies and guidelines. BMJ. 2011; 343: d5283; doi: 10.1136/bmj.d5283.
- 6, , , , , , . The effect of mobile phone text-message reminders on Kenyan health workers' adherence to malaria treatment guidelines: a cluster randomised trial. Lancet 2011; 378: 795–803.
- 7, , , , , . Electronic prescribing increases uptake of clinical pharmacologists' recommendations in the hospital setting. Br J Clin Pharmacol 2011; 72: 958–64.
- 8, , , , . Modifying prescribing behaviour of angiotensin receptor blockers by selectively rescinding managerial prior authorization requirements for losartan. Br J Clin Pharmacol 2011; 72: 997–1001.
- 9, , , , . Memory disorders associated with consumption of drugs: updating through a case/non-case study in the French PharmacoVigilance Database. Br J Clin Pharmacol 2011; 72: 898–904.
- 10, , , . Benefits and strengths of the disproportionality analysis for identification of adverse drug reactions in a pharmacovigilance database. Br J Clin Pharmacol 2011; 72: 905–8.
- 11. When to publish measures of disproportionality derived from spontaneous reporting databases? Br J Clin Pharmacol 2011; 72: 909–11.
- 12, , . Comparing patients' and healthcare professionals' ADR reports after media attention: the broadcast of a Dutch television programme about the benefits and risks of statins as an example. Br J Clin Pharmacol 2009; 67: 558–64.
- 13, , , . Media attention and the influence on the reporting odds ratio in disproportionality analysis: an example of patient reporting of statins. Pharmacoepidemiol Drug Saf 2010; 19: 26–32.